Conventional wisdom holds that orphan drugs treat rare (by definition) and more severe diseases. Because they treat diseases with significant unmet needs, their health benefits per person are large. But are they really? Does conventional wisdom align with the evidence? To answer the question myself and colleagues at FTI Consulting, including co-author Marie Steele-Adjognon, conducted…
[Sponsored] Explore how integrated workflow solutions—powered by Veradigm’s suite of products—can transform your operations into a more efficient, connected healthcare system. The post From Data Silos to Integrated Care: Driving Provider Engagement appeared first on MedCity News.
SUITLAND, Maryland — En una lavandería SuperSuds en el borde sur con Washington, D.C., un flujo constante de clientes cargaba ropa en lavadoras y secadoras un domingo por la mañana reciente, mientras esperaban mirando sus teléfonos o la televisión. En medio del suave zumbido de la ropa centrifugándose, Adrienne Jones inició su ronda vistiendo una…
Halozyme views its drug delivery technology for biologic medicines as complementary to Evotec’s biologic drug manufacturing capabilities. But according to Halozyme, Evotec was unwilling to engage in any merger discussions. The post Halozyme Pulls €2B Acquisition Bid as Evotec Commits to Standalone Strategy appeared first on MedCity News.
it is essential that more individuals receive high-quality, evidence-based primary care. While government agencies are working towards this objective, significant efforts can also be made at the community level and by independent primary care providers. The post 4 Ways to Help Vulnerable Patients Engage with Primary Care appeared first on MedCity News.
As Congressional Republicans and President Trump search for trillions of dollars in cuts to mandatory federal spending that could help offset the cost of extending expiring tax cuts, this brief analyzes current support from the federal government for health programs and services, including both spending and tax subsidies as context for those federal budget discussions.
Industry experts discuss cybersecurity within healthcare organizations at the annual HIMSS conference
By JEFF GOLDMSITH As health systems struggle to emerge from the post-COVID financial crisis, the importance of the clinical enterprise to these systems has dramatically increased. Healthcare organizations are getting larger, as failing enterprises are absorbed into growing systems. Yet clinicians of all stripes but particularly physicians feel a deepening sense of alienation from the…
Bain Capital’s buyout of Mitsubishi Tanabe Pharma brings a company with a drug portfolio and pipeline in areas such as immunology, central nervous system disorders, and metabolic disease. This business is the pharmaceuticals division of Japanese conglomerate Mitsubishi Chemical Group. The post Bain Capital Broadens Its Biotech Reach With $3.3B Deal for Mitsubishi Tanabe Pharma…
Spending cuts, immigration, and Medicaid are at the top of the Washington agenda. That climate provides fertile ground for misinformation and myths to multiply on social networks. Some of the most common are those surrounding immigrants, Latinos, and Medicaid. These claims include assertions that Latinos who use Medicaid, the federal-state program for low-income people and…